GRANULES vs SANOFICONR: Stock Comparison

GRANULES INDIA vs SANOFI CONS HEALTHC IND LUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. GRANULES INDIA shows a lower P/E, while SANOFI CONS HEALTHC IND L shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 4; SANOFICONR leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESSANOFICONR

Valuation lens

What price are you paying?

Market CapContext only
₹22,541 Cr
₹9,314 Cr
P/E RatioGRANULES has the lower reading
33.73x
35.01x
P/B RatioGRANULES has the lower reading
4.43x
26.77x
EPSSANOFICONR has the higher reading
₹7.26
₹29.87
Book ValueContext only
₹205.21
₹166.73
Dividend YieldSANOFICONR has the higher reading
0.19%
1.85%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹22,541 Cr vs ₹9,314 Cr
P/E Ratio
GRANULES has a lower P/E
33.73x vs 35.01x
P/B Ratio
GRANULES has a lower P/B
4.43x vs 26.77x
EPS
SANOFICONR has higher earnings per share
₹29.87 vs ₹7.26
Dividend Yield
SANOFICONR has a higher dividend yield
1.85% vs 0.19%
Revenue Growth (TTM YoY)
SANOFICONR has faster revenue growth
32.8% vs 22.8%
EPS Growth (TTM YoY)
SANOFICONR has faster EPS growth
35.7% vs 31.3%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
84.16% vs 2.84%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESSANOFICONR
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESSANOFICONR
Live Price₹909.3₹4,023.4
Day Change1.12%-1.62%
Volume78.51 L4,396
52-Week High₹910₹5,357
52-Week Low₹510.55₹3,975
Distance from 52W High-0.08%-24.89%

Valuation

MetricGRANULESSANOFICONR
Market Cap₹22,541 Cr₹9,314 Cr
P/E Ratio33.73x35.01x
P/B Ratio4.43x26.77x
EPS₹7.26₹29.87
Book Value₹205.21₹166.73
Dividend Yield0.19%1.85%

Growth

MetricGRANULESSANOFICONR
Revenue Growth (TTM YoY)22.8%32.8%
EPS Growth (TTM YoY)31.3%35.7%
Qtr Sales Growth84.16%2.84%
Qtr Profit Growth150.83%1.47%

Profitability & Leverage

MetricGRANULESSANOFICONR
ROE9.11%67.16%
ROCE9.07%2,813.76%
Net Margin11.15%27.58%
Operating Margin17.19%37.04%
Debt to Equity0.17x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESSANOFICONR
Promoter Holding37.67%
FII Holding17.5% 2.19 pp2.6% 0.16 pp
DII Holding16.11% 0.9 pp17.86% 0.29 pp
Public Holding28.38% 1.28 pp8.27% 0.13 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and SANOFI CONS HEALTHC IND L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.